3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
Chronic hyperhomocysteinemia (HHcy) is an important factor in development of arterial hypertension. HHcy is associated with activation of matrix metalloproteinases (MMPs); however, it is unclear whether HHcy-dependent extracellular matrix (ECM) accumulation plays a role in arterial hypertrophy and hypertension. We tested the hypothesis that in HHcy the mechanism of arterial hypertension involves arterial dysfunction in response to ECM accumulation between endothelial and arterial smooth muscle cells and subsequent endothelium-myocyte (E-M) uncoupling. To decrease plasma Hcy, dietary supplementation with 3-deazaadenosine (DZA), the S-adenosylhomocysteine hydrolase inhibitor, was administered to cystathionine beta-synthase (CBS) knockout (KO) mice. Mice were grouped as follows: wild type (WT; control), WT+DZA, CBSKO, and CBSKO+DZA (n = 4/group). Mean aortic blood pressure and heart rate were monitored in real time with a telemetric system before, during, and after DZA treatment (6 wk total). In vivo aorta function and morphology were analyzed by M-mode and Doppler echocardiography in anesthetized mice. Aorta MMP activity in unfixed cryostat sections was measured with DQ gelatin. Aorta MMP-2, MMP-9, and connexin 43 expression were measured by RT-PCR and Western blot analyses, respectively. HHcy caused increased aortic blood pressure and resistance, tachycardia, and increased wall thickness and ECM accumulation in aortic wall vs. control groups. There was a linear correlation between aortic wall thickness and plasma Hcy levels. MMP-2, MMP-9, and connexin 43 expression were increased in HHcy. In the CBSKO+DZA group, aortic blood pressure and levels of MMP and connexin 43 were close to those found in control groups. However, removal of DZA reversed the aortic lumen-to-wall thickness ratio in CBSKO mice, suggesting, in part, a role of vascular remodeling in the increase in blood pressure in HHcy. The results show that arterial hypertension in HHcy mice is, in part, associated with arterial remodeling and E-M uncoupling in response to MMP activation.
Ovechkin
Alexander V
AV
Department of Physiology & Biophysics, Health Sciences Center A-1115, School of Medicine, University of Louisville, KY 40202, USA.
Tyagi
Neetu
N
Sen
Utpal
U
Lominadze
David
D
Steed
Mesia M
MM
Moshal
Karni S
KS
Tyagi
Suresh C
SC
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001011:Aorta / Q000000981:diagnostic imaging / Q000201:enzymology / Q000473:pathology; D001794:Blood Pressure; D018031:Connexin 43 / Q000235:genetics / Q000378:metabolism; D003541:Cystathionine beta-Synthase / Q000235:genetics / Q000378:metabolism; D004452:Echocardiography; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D005109:Extracellular Matrix / Q000201:enzymology; D005260:Female; D006339:Heart Rate; D006710:Homocysteine / Q000097:blood; D020138:Hyperhomocysteinemia / Q000150:complications*; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014372:Tubercidin / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D018031:Connexin 43; C018258:3-deazaadenosine; D006710:Homocysteine; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D003541:Cystathionine beta-Synthase; D014372:Tubercidin